BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cacciapuoti F, Scognamiglio A, Palumbo R, Forte R, Cacciapuoti F. Silymarin in non alcoholic fatty liver disease. World J Hepatol 2013; 5(3): 109-113 [PMID: 23556042 DOI: 10.4254/wjh.v5.i3.109]
URL: https://www.wjgnet.com/1007-9327/full/v5/i3/109.htm
Number Citing Articles
1
Sheng Zhong, Yuxiang Fan, Qi Yan, Xingyu Fan, Bo Wu, Yujuan Han, Ying Zhang, Yong Chen, Huimao Zhang, Junqi Niu. The therapeutic effect of silymarin in the treatment of nonalcoholic fatty diseaseMedicine 2017; 96(49): e9061 doi: 10.1097/MD.0000000000009061
2
Tingting Yan, Nana Yan, Ping Wang, Yangliu Xia, Haiping Hao, Guangji Wang, Frank J. Gonzalez. Herbal drug discovery for the treatment of nonalcoholic fatty liver diseaseActa Pharmaceutica Sinica B 2020; 10(1): 3 doi: 10.1016/j.apsb.2019.11.017
3
Bo Zhang, Fang Ding, Tian Chen, Liang-Hua Xia, Juan Qian, Guo-Yi Lv. Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat contentWorld Journal of Gastroenterology 2014; 20(47): 17985-17992 doi: 10.3748/wjg.v20.i47.17985
4
Jayagopalan Veena, Anjaneyulu Muragundla, Srinivas Sidgiddi, Swaminathan Subramaniam. Non-alcoholic fatty liver disease: need for a balanced nutritional sourceBritish Journal of Nutrition 2014; 112(11): 1858 doi: 10.1017/S0007114514002591
5
M. Kasi Reddy, A. Gopala Reddy, B. Kala Kumar, D. Madhuri, G. Boobalan, M. Anudeep Reddy. Protective effect of rutin in comparison to silymarin against induced hepatotoxicity in ratsVeterinary World 2017; 10(1): 74 doi: 10.14202/vetworld.2017.74-80
6
Amera Abd El Latif, Doaa H. Assar, Ebtihal M. Elkaw, Hanafy A. Hamza, Dalal Hussien M. Alkhalifah, Wael N. Hozzein, Ragaa A. Hamouda. Protective role of Chlorella vulgaris with Thiamine against Paracetamol induced toxic effects on haematological, biochemical, oxidative stress parameters and histopathological changes in Wistar ratsScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83316-8
7
Samah M. El Sohafy, Aly M. Metwally, Abdalla A. Omar, Masouda E. Amer, Mohamed M. Radwan, Maged S. Abdel-Kader, Sayed A. El Toumy, Mahmoud A. ElSohly. Cornigerin, a new sesqui-lignan from the hepatoprotective fractions of Cynara cornigera LFitoterapia 2016; 115: 101 doi: 10.1016/j.fitote.2016.09.015
8
Eudmar Marcolino Assis-Júnior, Anielle Torres Melo, Venúcia Bruna Magalhães Pereira, Deysi Viviana Tenazoa Wong, Nathalia Ribeiro Pinho Sousa, Christiane Mendes Gonçalves Oliveira, Lara Raissa Cavalcante Malveira, Leonardo Silva Moreira, Marcellus Henrique Loiola Ponte Souza, Paulo Roberto Carvalho Almeida, Roberto César Pereira Lima-Júnior. Dual effect of silymarin on experimental non-alcoholic steatohepatitis induced by irinotecanToxicology and Applied Pharmacology 2017; 327: 71 doi: 10.1016/j.taap.2017.04.023
9
Marinko Marušić, Matej Paić, Mia Knobloch, Ana-Marija Liberati Pršo, Branka Filipović. NAFLD, Insulin Resistance, and Diabetes Mellitus Type 2Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/6613827
10
Halil Beydilli, Nigar Yilmaz, Esin Sakalli Cetin, Yasar Topal, Ozgur Ilhan Celik, Cem Sahin, Hatice Topal, Ibrahim Hakki Cigerci, Hamdi Sozen. Evaluation of the Protective Effect of Silibinin Against Diazinon Induced Hepatotoxicity and Free-Radical Damage in Rat LiverIranian Red Crescent Medical Journal 2015; 17(4) doi: 10.5812/ircmj.17(4)2015.25310
11
Hironori Kitade, Guanliang Chen, Yinhua Ni, Tsuguhito Ota. Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New TreatmentsNutrients 2017; 9(4): 387 doi: 10.3390/nu9040387
12
Yuan XIE, Hai-Ping HAO, Hong WANG, Zhao-Xian WANG, Guang-Ji WANG. Reversing effects of silybin on TAA-induced hepatic CYP3A dysfunction through PXR regulationChinese Journal of Natural Medicines 2013; 11(6): 645 doi: 10.1016/S1875-5364(13)60075-8
13
Thabani Mpanza, Myalowenkosi I. Sabela, Sanele S. Mathenjwa, Suvardhan Kanchi, Krishna Bisetty. Electrochemical Determination of Capsaicin and Silymarin Using a Glassy Carbon Electrode Modified by Gold Nanoparticle Decorated Multiwalled Carbon NanotubesAnalytical Letters 2014; 47(17): 2813 doi: 10.1080/00032719.2014.924010
14
Qiang Ou, Yuanyuan Weng, Siwei Wang, Yajuan Zhao, Feng Zhang, Jianhua Zhou, Xiaolin Wu. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB PathwayDigestive Diseases and Sciences 2018; 63(12): 3398 doi: 10.1007/s10620-018-5268-0
15
Kaan Demiroren, Mehmet Turan Basunlu, Remzi Erten, Erdem Cokluk. A comparison of the effects of thymoquinone, silymarin and N-acetylcysteine in an experimental hepatotoxicityBiomedicine & Pharmacotherapy 2018; 106: 1705 doi: 10.1016/j.biopha.2018.07.125
16
Ali Kemal Onalan, Salih Tuncal, Sibel Kilicoglu, Salih Celepli, Esra Durak, Bulent Kilicoglu, Erdinc Devrim, Aziz Mutlu Barlas, Kemal Kismet. Effect of sılymarın on oxıdatıve stress and lıver hıstopathology ın experımental obstructıve jaundıce modelActa Cirurgica Brasileira 2016; 31(12): 801 doi: 10.1590/s0102-865020160120000004
17
Sean P. Tighe, Daud Akhtar, Umair Iqbal, Aijaz Ahmed. Chronic Liver Disease and Silymarin: A Biochemical and Clinical ReviewJournal of Clinical and Translational Hepatology 2020; 8(4): 1 doi: 10.14218/JCTH.2020.00012
18
Licia Polimeni, Maria Del Ben, Francesco Baratta, Ludovica Perri, Fabiana Albanese, Daniele Pastori, Francesco Violi, Francesco Angelico. Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosisWorld Journal of Hepatology 2015; 7(10): 1325-1336 doi: 10.4254/wjh.v7.i10.1325
19
Kasi Pandima Devi. Nonvitamin and Nonmineral Nutritional Supplements2019; : 321 doi: 10.1016/B978-0-12-812491-8.00046-1
20
Paola Nogueira Coutinho, Beatriz Peters Pereira, Ana Claudia Hertel Pereira, Marcella Leite Porto, Arícia Leone Evangelista Monteiro de Assis, Afrânio Côgo Destefani, Silvana Santos Meyrelles, Elisardo Corral Vasquez, Breno Valentim Nogueira, Tadeu Uggere de Andrade, Denise Coutinho Endringer, Marcio Fronza, Thiago Melo Costa Pereira. Chronic administration of antioxidant resin from Virola oleifera attenuates atherogenesis in LDLr -/- miceJournal of Ethnopharmacology 2017; 206: 65 doi: 10.1016/j.jep.2017.05.015
21
Michal Bijak, Ewelina Synowiec, Przemyslaw Sitarek, Tomasz Sliwiński, Joanna Saluk-Bijak. Evaluation of the Cytotoxicity and Genotoxicity of Flavonolignans in Different Cellular ModelsNutrients 2017; 9(12): 1356 doi: 10.3390/nu9121356
22
Jean M. Bokelmann. Medicinal Herbs in Primary Care2022; : 495 doi: 10.1016/B978-0-323-84676-9.00061-1
23
Ali Taghipour, Fatemeh Ghaffarifar, John Horton, Abdolhossein Dalimi, Zohreh Sharifi. Silybum marianum ethanolic extract: in vitro effects on protoscolices of Echinococcus granulosus G1 strain with emphasis on other Iranian medicinal plantsTropical Medicine and Health 2021; 49(1) doi: 10.1186/s41182-021-00363-7
24
Hamdi Sozen, Ozgür Ilhan Celik, Esin Sakalli Cetin, Nigar Yilmaz, Alper Aksozek, Yasar Topal, Ibrahim Hakkı Cigerci, Halil Beydilli. Evaluation of the Protective Effect of Silibinin in Rats with Liver Damage Caused by ItraconazoleCell Biochemistry and Biophysics 2015; 71(2): 1215 doi: 10.1007/s12013-014-0331-8
25
Gülen Arslan Lied, Odd Helge Gilja, Trygve Hausken. Har silibinin en plass i behandlingen av leversykdommer?Tidsskrift for Den norske legeforening 2014; 134(4): 392 doi: 10.4045/tidsskr.13.1531
26
Navaneethakrishnan Polachi, Guirong Bai, Tingyang Li, Yang Chu, Xiangyang Wang, Shuming Li, Ning Gu, Jiang Wu, Wei Li, Yanjun Zhang, Shuiping Zhou, He Sun, Changxiao Liu. Modulatory effects of silibinin in various cell signaling pathways against liver disorders and cancer – A comprehensive reviewEuropean Journal of Medicinal Chemistry 2016; 123: 577 doi: 10.1016/j.ejmech.2016.07.070
27
Chan Wah Kheong, Nik Raihan Nik Mustapha, Sanjiv Mahadeva. A Randomized Trial of Silymarin for the Treatment of Nonalcoholic SteatohepatitisClinical Gastroenterology and Hepatology 2017; 15(12): 1940 doi: 10.1016/j.cgh.2017.04.016
28
Manuel Suárez, Noemí Boqué, Josep del Bas, Jordi Mayneris-Perxachs, Lluís Arola, Antoni Caimari. Mediterranean Diet and Multi-Ingredient-Based Interventions for the Management of Non-Alcoholic Fatty Liver DiseaseNutrients 2017; 9(10): 1052 doi: 10.3390/nu9101052
29
Aleksandra Kołota, Dominika Głąbska. Dietary Intake of Milk Thistle Seeds as a Source of Silymarin and Its Influence on the Lipid Parameters in Nonalcoholic Fatty Liver Disease PatientsApplied Sciences 2021; 11(13): 5836 doi: 10.3390/app11135836
30
Veronica Marin, Silvia Gazzin, Sabrina Gambaro, Matteo Dal Ben, Sonia Calligaris, Monica Anese, Alan Raseni, Claudio Avellini, Pablo Giraudi, Claudio Tiribelli, Natalia Rosso. Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic SteatohepatitisNutrients 2017; 9(9): 1006 doi: 10.3390/nu9091006
31
Mohammed Sikander, Shabnam Malik, Anyssa Rodriguez, Murali M. Yallapu, Acharan S. Narula, Sanjaya K. Satapathy, Vijian Dhevan, Subhash C. Chauhan, Meena Jaggi. Role of Nutraceuticals in COVID-19 Mediated Liver DysfunctionMolecules 2020; 25(24): 5905 doi: 10.3390/molecules25245905
32
Abdo Mahli, Andreas Koch, Barbara Czech, Philipp Peterburs, Anja Lechner, Jutta Haunschild, Martina Müller, Claus Hellerbrand. Hepatoprotective effect of oral application of a silymarin extract in carbon tetrachloride-induced hepatotoxicity in ratsClinical Phytoscience 2015; 1(1) doi: 10.1186/s40816-015-0006-z
33
Anis Ben Hsouna, Sabah Dhibi, Wissal Dhifi, Wissem Mnif, hmed Ben Nasr, Najla Hfaiedh. Chemical composition and hepatoprotective effect of essential oil from Myrtus communis L. flowers against CCL4-induced acute hepatotoxicity in ratsRSC Advances 2019; 9(7): 3777 doi: 10.1039/C8RA08204A
34
John E. Poulos, Peter T. Kalogerinis, Valentin Milanov, Constantine T. Kalogerinis, Emanuel J. Poulos. The Effects of Vitamin E, Silymarin and Carnitine on the Metabolic Abnormalities Associated with Nonalcoholic Liver DiseaseJournal of Dietary Supplements 2021; : 1 doi: 10.1080/19390211.2021.1874587
35
Brandon Perumpail, Andrew Li, Umair Iqbal, Sandy Sallam, Neha Shah, Waiyee Kwong, George Cholankeril, Donghee Kim, Aijaz Ahmed. Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLDDiseases 2018; 6(3): 80 doi: 10.3390/diseases6030080
36
Jung-Hyo Cho, Jong-Suk Lee, Hyeong-Geug Kim, Hye Won Lee, Zhigang Fang, Hyeok-Hee Kwon, Dong Woon Kim, Chang-Min Lee, Jin-Woo Jeong. Ethyl Acetate Fraction of Amomum villosum var. xanthioides Attenuates Hepatic Endoplasmic Reticulum Stress-Induced Non-Alcoholic Steatohepatitis via Improvement of Antioxidant CapacitiesAntioxidants 2021; 10(7): 998 doi: 10.3390/antiox10070998
37
Priscila O. Barbosa, Melina O. Souza, Maraísa P.S. Silva, Gabrielly T. Santos, Marcelo E. Silva, Giovanna Bermano, Renata N. Freitas. Açaí (Euterpe oleracea Martius) supplementation improves oxidative stress biomarkers in liver tissue of dams fed a high-fat diet and increases antioxidant enzymes’ gene expression in offspringBiomedicine & Pharmacotherapy 2021; 139: 111627 doi: 10.1016/j.biopha.2021.111627
38
Antonietta Stellavato, Anna Virginia Adriana Pirozzi, Francesca de Novellis, Ilaria Scognamiglio, Valentina Vassallo, Andrea Maria Giori, Mario De Rosa, Chiara Schiraldi. In vitro assessment of nutraceutical compounds and novel nutraceutical formulations in a liver-steatosis-based modelLipids in Health and Disease 2018; 17(1) doi: 10.1186/s12944-018-0663-2
39
Ludovico Abenavoli, Angelo A. Izzo, Natasa Milić, Carla Cicala, Antonello Santini, Raffaele Capasso. Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseasesPhytotherapy Research 2018; 32(11): 2202 doi: 10.1002/ptr.6171
40
Nancy Vargas-Mendoza, Eduardo Madrigal-Santillán, Ángel Morales-González, Jaime Esquivel-Soto, Cesar Esquivel-Chirino, Manuel García-Luna y González-Rubio, Juan A Gayosso-de-Lucio, José A Morales-González. Hepatoprotective effect of silymarinWorld Journal of Hepatology 2014; 6(3): 144-149 doi: 10.4254/wjh.v6.i3.144
41
Asal Sarrafan, Maryam Ghobeh, Parichehreh Yaghmaei. The effect of 6-gingerol on biochemical and histological parameters in cholesterol-induced nonalcoholic fatty liver disease in NMRI miceBrazilian Journal of Pharmaceutical Sciences 2021; 57 doi: 10.1590/s2175-979020200003181020
42
Eun-Jung Park, You-Suk Lee, Sung Min Kim, Gun-Seok Park, Yong Hyun Lee, Do Yeun Jeong, Jihee Kang, Hae-Jeung Lee. Beneficial Effects of Lactobacillus plantarum Strains on Non-Alcoholic Fatty Liver Disease in High Fat/High Fructose Diet-Fed RatsNutrients 2020; 12(2): 542 doi: 10.3390/nu12020542
43
Gianni Testino, Silvia Leone, Sharmila Fagoonee, Rinaldo Pellicano. Alcoholic liver fibrosis: detection and treatmentMinerva Medica 2018; 109(6) doi: 10.23736/S0026-4806.18.05844-5
44
Fang Liu, Meng Wang, Yang Wang, Yiwei Cao, Zhaolin Sun, Mingcang Chen, Xiaoting Tian, Jianbo Wan, Chenggang Huang. Metabonomics Study on the Hepatoprotective Effect of Panax notoginseng Leaf Saponins Using UPLC/Q-TOF-MS AnalysisThe American Journal of Chinese Medicine 2019; 47(03): 559 doi: 10.1142/S0192415X19500290
45
Faezeh Abbasirad, Vahid Shaygannejad, Fahimeh Hosseininasab, Omid Mirmosayyeb, Behzad Mahaki, Behjat Moayedi, Nafiseh Esmaeil. Significant immunomodulatory and hepatoprotective impacts of Silymarin in MS patients: A double-blind placebo-controlled clinical trialInternational Immunopharmacology 2021; 97: 107715 doi: 10.1016/j.intimp.2021.107715
46
Masoumeh Akhlaghi. Non-alcoholic Fatty Liver Disease: Beneficial Effects of FlavonoidsPhytotherapy Research 2016; 30(10): 1559 doi: 10.1002/ptr.5667
47
Annalisa Curcio, Adriana Romano, Simona Cuozzo, Antonio Di Nicola, Orazio Grassi, Donatella Schiaroli, Giuseppe Fabrizio Nocera, Michele Pironti. Silymarin in Combination with Vitamin C, Vitamin E, Coenzyme Q10 and Selenomethionine to Improve Liver Enzymes and Blood Lipid Profile in NAFLD PatientsMedicina 2020; 56(10): 544 doi: 10.3390/medicina56100544
48
Francesca Maria Trovato, Daniela Catalano, Giuseppe Musumeci, Guglielmo M Trovato. 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine—recommendations for facing obesity, fatty liver and fibrosis epidemicsEPMA Journal 2014; 5(1) doi: 10.1186/1878-5085-5-21
49
Maria Del Ben, Licia Polimeni, Francesco Baratta, Daniele Pastori, Francesco Angelico. The role of nutraceuticals for the treatment of non-alcoholic fatty liver diseaseBritish Journal of Clinical Pharmacology 2017; 83(1): 88 doi: 10.1111/bcp.12899
50
L. Abenavoli, N. Milic. Liver Pathophysiology2017; : 621 doi: 10.1016/B978-0-12-804274-8.00045-X
51
Beniamino PALMIERI, Veronica CORAZZARI, Diana G. PANARIELLO BRASILE, Vincenzo SANGIOVANNI, Maria VADALÀ. Hepatic steatosis integrated approach: nutritional guidelines and joined nutraceutical administrationMinerva Gastroenterologica e Dietologica 2021; 66(4) doi: 10.23736/S1121-421X.20.02738-5
52
Alper Sonmez, Cemal Nuri Ercin, Mustafa Cesur, Teoman Dogru. Nutraceuticals and Cardiovascular DiseaseContemporary Cardiology 2021; : 141 doi: 10.1007/978-3-030-62632-7_9
53
Masoumeh Asgarshirazi, Mamak Shariat, Mahdi Sheikh. Comparison of efficacy of folic acid and silymarin in the management of antiepileptic drug induced liver injury: a randomized clinical trialHepatobiliary & Pancreatic Diseases International 2017; 16(3): 296 doi: 10.1016/S1499-3872(16)60142-X
54
Samarth Siddharth Patel, Mohammad Shadab Siddiqui. Current and Emerging Therapies for Non-alcoholic Fatty Liver DiseaseDrugs 2019; 79(1): 75 doi: 10.1007/s40265-018-1040-1
55
Maryam Vahabzadeh, Nafise Amiri, Gholamreza Karimi. Effects of silymarin on metabolic syndrome: a reviewJournal of the Science of Food and Agriculture 2018; 98(13): 4816 doi: 10.1002/jsfa.9115
56
Ludovico Abenavoli, Valentina Peta, Natasa Milic. Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case seriesAnnals of Hepatology 2015; 14(1): 121 doi: 10.1016/S1665-2681(19)30809-9
57
Shiv Chitturi, Vincent Wai-Sun Wong, Wah-Kheong Chan, Grace Lai-Hung Wong, Simon Kin-Hung Wong, Jose Sollano, Yen-Hsuan Ni, Chun-Jen Liu, Yu-Cheng Lin, Laurentius Adrianto Lesmana, Seung Up Kim, Etsuko Hashimoto, Masahide Hamaguchi, Khean-Lee Goh, Jiangao Fan, Ajay Duseja, Yock Young Dan, Yogesh Chawla, Geoff Farrell, Henry Lik-Yuen Chan. The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groupsJournal of Gastroenterology and Hepatology 2018; 33(1): 86 doi: 10.1111/jgh.13856
58
Wonjong Lee, Dong Gun Lee. Potential role of potassium and chloride channels in regulation of silymarin-induced apoptosis in Candida albicans IUBMB Life 2018; 70(3): 197 doi: 10.1002/iub.1716
59
Francesca M. Trovato, Daniela Catalano, Giuseppe F. Martines, Guglielmo M. Trovato. Coffee in Health and Disease Prevention2015; : 567 doi: 10.1016/B978-0-12-409517-5.00064-4
60
Jia Xiao, Feiyue Xing, Jie Huo, Man Lung Fung, Emily C. Liong, Yick Pang Ching, Aimin Xu, Raymond Chuen Chung Chang, Kwok Fai So, George L. Tipoe. Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis modelScientific Reports 2015; 4(1) doi: 10.1038/srep05587
61
Devaraj Ezhilarasan. Phytochemicals as Lead Compounds for New Drug Discovery2020; : 195 doi: 10.1016/B978-0-12-817890-4.00012-3
62
Jeongeun Mun, Shintae Kim, Ho-Geun Yoon, Yanghee You, Ok-Kyung Kim, Kyung-Chul Choi, Yoo-Hyun Lee, Jeongmin Lee, Jeongjin Park, Woojin Jun. Water Extract of Curcuma longa L. Ameliorates Non-Alcoholic Fatty Liver DiseaseNutrients 2019; 11(10): 2536 doi: 10.3390/nu11102536
63
Tingting Shi, Li Wu, Wenjun Ma, Liping Ju, Minghui Bai, Xiaowei Chen, Shourong Liu, Xingxin Yang, Junping Shi. Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western MedicineEvidence-Based Complementary and Alternative Medicine 2020; 2020: 1 doi: 10.1155/2020/8749564